Cargando…

Barriers, facilitators, and solutions to familial hypercholesterolemia treatment

BACKGROUND: Familial hypercholesterolemia (FH) is an inherited lipid disorder that confers high risk for premature cardiovascular disease but remains undertreated. Causes are multifactorial and multilevel, ranging from underprescribing (at the clinician-level) to medication nonadherence (at the pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jones, Laney K., Sturm, Amy C., Seaton, Terry L., Gregor, Christina, Gidding, Samuel S., Williams, Marc S., Rahm, Alanna Kulchak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757879/ https://www.ncbi.nlm.nih.gov/pubmed/33362269 http://dx.doi.org/10.1371/journal.pone.0244193

Ejemplares similares

Implementation strategies to improve statin utilization in individuals with hypercholesterolemia: a systematic review and meta-analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Patient experiences align with the familial hypercholesterolemia global call to action
por: Jones, Laney K., et al.
Publicado: (2022)

Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach
por: Jones, Laney K., et al.
Publicado: (2023)

Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study
por: Jones, Laney K., et al.
Publicado: (2021)

Collaborative Approach to Reach Everyone with Familial Hypercholesterolemia: CARE-FH Protocol
por: Jones, Laney K., et al.
Publicado: (2022)

Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2021)

Evaluation of a multidisciplinary lipid clinic to improve the care of individuals with severe lipid conditions: a RE-AIM framework analysis
por: Jones, Laney K., et al.
Publicado: (2021)

Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia
por: Campbell-Salome, Gemme, et al.
Publicado: (2023)

Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review
por: Hendricks-Sturrup, Rachele M., et al.
Publicado: (2019)

Applying implementation science to improve care for familial hypercholesterolemia
por: Jones, Laney K., et al.
Publicado: (2022)

Impact of a Population Genomic Screening Program on Health Behaviors Related to Familial Hypercholesterolemia Risk Reduction
por: Jones, Laney K., et al.
Publicado: (2022)

Yield of Familial Hypercholesterolemia Genetic and Phenotypic Diagnoses After Electronic Health Record and Genomic Data Screening
por: Gidding, Samuel S., et al.
Publicado: (2023)

Facilitating family communication of familial hypercholesterolemia genetic risk: Assessing engagement with innovative chatbot technology from the IMPACT-FH study
por: Walters, Nicole L., et al.
Publicado: (2023)

Generation and Implementation of a Patient-Centered and Patient-Facing Genomic Test Report in the EHR
por: Goehringer, Jessica M., et al.
Publicado: (2018)

Understanding the Patient Experience of Receiving Clinically Actionable Genetic Results from the MyCode Community Health Initiative, a Population-Based Genomic Screening Initiative
por: Baker, Anna, et al.
Publicado: (2022)

Developing Pharmacogenomic Reports: Insights from Patients and Clinicians
por: Jones, Laney K., et al.
Publicado: (2018)

Hidden Burden of Electronic Health Record‐Identified Familial Hypercholesterolemia: Clinical Outcomes and Cost of Medical Care
por: Patel, Prashant, et al.
Publicado: (2019)

Alternate Service Delivery Models in Cancer Genetic Counseling: A Mini-Review
por: Buchanan, Adam Hudson, et al.
Publicado: (2016)

Racial Disparities in Modifiable Risk Factors and Statin Usage in Black Patients With Familial Hypercholesterolemia
por: Agarwala, Anandita, et al.
Publicado: (2021)

Motivating cascade testing for familial hypercholesterolemia: applying the extended parallel process model for clinician communication
por: Campbell-Salome, Gemme, et al.
Publicado: (2022)

Clinical characterization of familial hypercholesterolemia due to an amish founder mutation in Apolipoprotein B
por: Williams, Katie B., et al.
Publicado: (2022)

A RE-AIM Framework Analysis of DNA-Based Population Screening: Using Implementation Science to Translate Research Into Practice in a Healthcare System
por: Jones, Laney K., et al.
Publicado: (2022)

Mapping of familial hypercholesterolemia and dyslipidemias basic management infrastructure in Pakistan: a cross-sectional study
por: Sadiq, Fouzia, et al.
Publicado: (2023)

Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program
por: Hao, Jing, et al.
Publicado: (2020)

User testing of a diagnostic decision support system with machine-assisted chart review to facilitate clinical genomic diagnosis
por: Kulchak Rahm, Alanna, et al.
Publicado: (2021)

Familial Hypercholesterolemia
por: Baruah, Dibya Kumar
Publicado: (2021)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

An update on lipid apheresis for familial hypercholesterolemia
por: Taylan, Christina, et al.
Publicado: (2022)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Patient advocacy: barriers and facilitators
por: Negarandeh, Reza, et al.
Publicado: (2006)

The burden of severe hypercholesterolemia and familial hypercholesterolemia in a population-based setting in the US
por: Saadatagah, Seyedmohammad, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Enhancing genomic laboratory reports from the patients' view: A qualitative analysis
por: Stuckey, Heather, et al.
Publicado: (2015)

Enhancing genomic laboratory reports: A qualitative analysis of provider review
por: Williams, Janet L., et al.
Publicado: (2016)

Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication
por: Williams, Janet L., et al.
Publicado: (2017)

Clinical outcomes of a genomic screening program for actionable genetic conditions
por: Buchanan, Adam H., et al.
Publicado: (2020)

Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis
por: Sturm, Amy C., et al.
Publicado: (2021)

Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care
por: Alonso, Rodrigo, et al.
Publicado: (2020)

Familial Hypercholesterolemia: The Lipids or the Genes?
por: Fahed, Akl C, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vipg49idkbiit8dltudjqt99l9